MicroRNA expression analysis of human skin fibroblasts treated with high-fluence light-emitting diode-red light

Area of Science:

• Dermatology and Molecular Biology
• Investigating the molecular mechanisms of skin fibrosis and novel therapeutic interventions.

Background:

• Skin fibrosis, characterized by fibroblast proliferation and collagen deposition, is driven by the transforming growth factor beta (TGF-B)/SMAD pathway.
• High-fluence light-emitting diode-generated red light (HF-LED-RL) is a safe, non-invasive therapy with potential to modulate fibrotic processes.
• Limited research exists on HF-LED-RL's effects on human skin fibroblast microRNAs (miRNAs).

Purpose of the Study:

• To explore the impact of HF-LED-RL on miRNA expression in human skin fibroblasts.
• To identify specific miRNAs modulated by HF-LED-RL that are relevant to skin fibrosis pathogenesis.

Main Methods:

• Utilized RNA sequencing (RNA-seq) and miRNA expression analysis.
• Exposed human skin fibroblasts to HF-LED-RL at energy densities of 320 J/cm² and 640 J/cm².
• Analyzed changes in miRNA transcription levels post-treatment.

Main Results:

• HF-LED-RL significantly altered the transcription of several key miRNAs involved in skin fibrosis.
• Increased transcription of fibrosis-associated miRNAs: miRNA-29, miRNA-196a, and Let-7a.
• Decreased transcription of fibrosis-associated miRNAs: miRNA-21, miRNA-23b, and miRNA-31.

Conclusions:

• The observed miRNA modulations provide insight into the molecular mechanisms of HF-LED-RL in treating skin fibrosis.
• Specific miRNAs identified represent potential therapeutic targets for skin fibrosis.
• Further research into the precise molecular mechanisms of HF-LED-RL is warranted to uncover additional therapeutic targets.